Related Experiment Videos
Summary
Chloroquine demonstrates mutagenic activity, specifically causing frameshift reversion in Salmonella typhimurium TA97 and Escherichia coli EE97/EE102 strains. This mutagenicity was observed at concentrations near therapeutic blood levels.
Area of Science:
- Microbiology
- Genetics
- Toxicology
Background:
- Chloroquine is an antimalarial drug with potential genotoxic effects.
- Assessing drug mutagenicity is crucial for understanding safety profiles.
Purpose of the Study:
- To evaluate the mutagenic potential of chloroquine.
- To identify specific mechanisms of chloroquine-induced mutations.
Main Methods:
- Utilized Ames plate reversion and fluctuation tests.
- Employed Salmonella typhimurium (TA97, TA102) and Escherichia coli (WP2, WP2hcr, WP6, WP67) tester strains.
- Tested E. coli transconjugants (EE97, EE102) harboring R-plasmids.
Main Results:
- Chloroquine induced frameshift reversion in Salmonella typhimurium TA97.
- Chloroquine also reverted Escherichia coli strains EE97 and EE102.
- Mutagenic effects were observed at therapeutic blood levels (250 ng/ml) and optimally at lower concentrations (25-50 µg/ml).
- No mutagenic effects were observed in E. coli WP2, WP2hcr, WP6, WP67, or S. typhimurium TA102.
Conclusions:
- Chloroquine exhibits mutagenic activity, primarily through a frameshift reversion mechanism.
- The study highlights the genotoxic potential of chloroquine, particularly at clinically relevant concentrations.